Systemic Amyloidosis due to Monoclonal Immunoglobulins, An Issue of Hematology/Oncology Clinics of North America
- 1 Edición, Volumen 34-6 - 27 de octubre de 2020
- Última edición
- Editor: Raymond L. Comenzo
- Idioma: Inglés
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six… Leer más
Descripción
Descripción
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: The Spectrum of Monoclonal Immunoglobulin Diseases, Systemic Amyloidosis due to Clonal Plasma Cell Diseases, Systemic Amyloidosis due to Low-grade Lymphomas, The Process of Amyloid Formation due to Monoclonal Immunoglobulins, Cardiac Involvement, Renal Involvement, Liver and Gastrointestinal Involvement, Peripheral Nervous System Involvement, Options for Chemotherapy, Stem-cell Mobilization and Autologous Transplant, Monoclonal Antibody Therapies, Solid Organ Transplant, Supportive Care, Patient Voices, and Future Perspectives.
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 34-6
- Publicado: 27 de octubre de 2020
- Idioma: Inglés
Sobre el editor
Sobre el editor
RC
Raymond L. Comenzo
Afiliaciones y experiencia
By Raymond L. Comenzo, MD.,
Director, Transfusion Services
Director, John C. Davis Myeloma and Amyloid Program
Professor, Tufts University School of Medicine
Tufts Medical Center and Tufts University School of Medicine
Boston, MA, USA